Westlake Village Biopartners, the California-based venture capital firm, said Monday it has raised another $450 million to invest in early-stage biotechnology companies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,